Sergio Traversa
Directeur Général chez RELMADA THERAPEUTICS, INC.
Fortune : 902 889 $ au 30/04/2024
Provenance du réseau au premier degré de Sergio Traversa
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 19 | |
Public Company | Pharmaceuticals: Major | 8 | |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV.
7
| Extinct | Financial Conglomerates | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Sergio Traversa via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ANTARES PHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel | |
PALATIN TECHNOLOGIES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin Director/Board Member | |
M&G Investment Management Ltd.
M&G Investment Management Ltd. Investment ManagersFinance M&G Investment Management Ltd. (MAGIM) is the asset management subsidiary of MG FA Ltd., ultimately owned by M&G Plc (LON: MNG) in Great Britain. Formerly known as Prudential Investment Management Ltd., the firm was founded in 1968 and is headquartered in London. MAGIM provides investment management for a broad range of clients, with a product range that includes segregated mandates for institutions as well as retail mutual funds for individuals. | Investment Managers | Head-Equity Investments | |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | Chairman | |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GENPREX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
BELLEROPHON THERAPEUTICS, INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Robeco Institutional Asset Management BV
Robeco Institutional Asset Management BV Investment ManagersFinance Robeco Institutional Asset Management BV (RIAM) is the Netherlands-based asset management subsidiary of Robeco Europe NV, itself a subsidiary of ORIX Corp. (TYO: 8591, ADR: IX), a Japanese business conglomerate that started operations in 1964. Headquartered in Rotterdam, the firm was founded in 1929 and provides investment products and services to institutional and private clients through locations in Europe, the US, the Middle East and Asia. RIAM is a socially responsible investor which engages in active dialogue with the companies in which they invest about good corporate governance and subjects of environmental or social interest. Their product range encompasses fixed-income, equity and alternative investments. | Investment Managers | Head-Equity Investments | |
University of Pennsylvania | College/University | Corporate Officer/Principal | |
University of Bath | College/University | Undergraduate Degree | |
MITHRA PHARMACEUTICALS S.A. | Pharmaceuticals: Major | Chairman | |
Rutgers State University of New Jersey | College/University | Undergraduate Degree Undergraduate Degree | |
Thomas Edison State College | College/University | Undergraduate Degree | |
Rider University | College/University | Masters Business Admin | |
University of Connecticut | College/University | Undergraduate Degree Undergraduate Degree | |
University of Kansas | College/University | Doctorate Degree | |
Wesleyan University | College/University | Undergraduate Degree | |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Corporate Officer/Principal | |
Saama Technologies, Inc.
Saama Technologies, Inc. Data Processing ServicesTechnology Services Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA. | Data Processing Services | Director/Board Member | |
University of Bocconi | College/University | Undergraduate Degree | |
Vlaams Instituut voor Biotechnologie - Flanders Institute
Vlaams Instituut voor Biotechnologie - Flanders Institute Other Consumer ServicesConsumer Services Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium. | College/University | Chairman | |
Soudal NV
Soudal NV Chemicals: SpecialtyProcess Industries Soudal NV engages in the manufacture and trade of sealants and adhesives. It offers polyurethane foams, hybrid polymers, technical aerosols, and chemical building products. The company was founded in 1966 and is headquartered in Turnhout, Belgium. | Chemicals: Specialty | Director/Board Member | |
Geller & Co. LLC
Geller & Co. LLC Financial ConglomeratesFinance Geller & Co. LLC and its subsidiary, Geller Advisors LLC, provide financial advisory and wealth management services to individuals, families, business owners, institutions, and non-profits. The private company is based in New York, NY and has subsidiaries in the United States. The company's services include CFO, financial, tax and estate planning, investment management, philanthropic giving, and technology. Geller Advisors is a multi-family office with over $9 billion of assets under management and advisement. The company was founded by Laurence Stephen Geller and Martin Jay Geller, with Martin Jay Geller serving as CEO since incorporation. | Financial Conglomerates | Corporate Officer/Principal | |
Trinity College, Cambridge | College/University | Doctorate Degree | |
Insmed Ltd.
Insmed Ltd. Pharmaceuticals: MajorHealth Technology Insmed Ltd. develops and manufactures pharmaceutical products for the treatment of lung diseases. Its products are used for the site-specific treatment of serious lung diseases such as pulmonary infections in cystic fibrosis patients and cancers affecting the lung. The company is located in London, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Deciphera Pharmaceuticals LLC discovers and develops pharmaceutical preparations. It designs kinase inhibitor therapies that target the hallmarks of cancer biology. The firm’s clinical pipeline of kinase inhibitors includes tumor-targeted therapies and immuno-targeted therapies. It offers DCC-2618, Rebastinib, and DCC-3014. The company was founded by Daniel L. Flynn in 2003 and is headquartered in Waltham, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Hitosubashi University | College/University | Graduate Degree | |
Robeco Institutional Asset Management US, Inc.
Robeco Institutional Asset Management US, Inc. Investment ManagersFinance Robeco Institutional Asset Management US, Inc. (RIAM US) is a SEC-registered investment adviser headquartered in New York City. The firm is a direct subsidiary of Robeco Holding BV, ultimately held by ORIX Corp. (TYO: 8591) in Japan. RIAM US provides investment advice primarily in global equity securities to US institutional investors on a fully discretionary basis. | Investment Managers | Portfolio Manager-Equities | |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
The University of Virginia School of Medicine | College/University | Doctorate Degree | |
ENTERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
COGENTIX MEDICAL INC | Medical Specialties | Director of Finance/CFO | |
GS1 AISBL
GS1 AISBL Miscellaneous Commercial ServicesCommercial Services GS1 AISBL is a Belgian company that provides supply chain standards to communicate with industry's customers, partners, and suppliers. The non-profit company is based in Brussels, BE, and has a global presence of subsidiaries in several regions. The company offers GS1 barcodes/GTINs that are necessary for most online and traditional retailers. The company optimizes the supply chain and life cycle management for Technical Industries. The company provides tools to calculate the check characters pair for the GMN and validate the structure and composition of the basic UDI-DI used for regulated healthcare medical devices. GS1 ID Keys give companies efficient ways to access information about items in their supply chains and share this information with trading partners. The company was founded in 1971, and the CEOs are Kathryn E. Wengel and Renaud de Barbuat. | Miscellaneous Commercial Services | Director/Board Member | |
Mcb Forum | Chairman | ||
Rejuvenate Biomed
Rejuvenate Biomed Medical/Nursing ServicesHealth Services Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation. | Medical/Nursing Services | Chairman | |
YishengBio Co., Ltd.
YishengBio Co., Ltd. BiotechnologyHealth Technology Yishengbio Co., Ltd. is an investment holding company that engages in the research and development, manufacture, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. It focuses on the PIKA immunomodulation technology platform and production, sale of YSJA rabies vaccine. Its geographical segment include Mainland China, and other countries. The company was founded by Yi Zhang on November 16, 2020 and is headquartered in China. | Biotechnology | Director/Board Member | |
LAKESHORE BIOPHARMA CO., LTD | Biotechnology | Chairman |
Statistiques
Internationale
Etats-Unis | 31 |
Royaume-Uni | 7 |
Belgique | 7 |
Pays-Bas | 2 |
France | 2 |
Sectorielle
Health Technology | 23 |
Consumer Services | 16 |
Finance | 7 |
Commercial Services | 4 |
Technology Services | 2 |
Opérationnelle
Director/Board Member | 80 |
Corporate Officer/Principal | 60 |
Undergraduate Degree | 28 |
Independent Dir/Board Member | 27 |
Director of Finance/CFO | 24 |
Relations les plus connectées
Insiders | |
---|---|
Charles Casamento | 27 |
Rosemary Mazanet | 24 |
C. Nicholson | 22 |
Ajit Shetty | 19 |
Maged Shenouda | 16 |
Richard Steinhart | 12 |
Royston Glasspool | 11 |
Dragan Cicic | 11 |
Sandesh Seth | 10 |
Mark Berger | 10 |
Gary Siegel | 9 |
John V. Talley | 9 |
Fabiana Fedeli | 8 |
Charles Ence | 8 |
Kaushik J. Dave | 7 |
- Bourse
- Insiders
- Sergio Traversa
- Connexions Sociétés